Finance

Lists
017180:KRX
Myungmoon Pharm Co Ltd
1 314,00 KRW
+0,38%
(+5,00) 1D
19 ოქტ, 15:30:28 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 017180...
Open
1 260 KRW
High
1 325 KRW
Low
1 260 KRW
Mkt. cap
44,61 მლრდ.
Avg. vol.
304,49 ათ.
Volume
33,05 ათ.
52-wk high
2 055 KRW
52-wk low
1 000 KRW
EPS
-49 KRW
Shares outstanding
33,95 მლნ.
No. of employees
319
Open
1 260 KRW
High
1 325 KRW
Low
1 260 KRW
Mkt. cap
44,61 მლრდ.
Avg. vol.
304,49 ათ.
Volume
33,05 ათ.
52-wk high
2 055 KRW
52-wk low
1 000 KRW
EPS
-49 KRW
Shares outstanding
33,95 მლნ.
No. of employees
319
News stories
From web sources and news partners
About Myungmoon Pharm Co Ltd
CEO-
Employees319
Founded1983
Headquarters-
SectorPharmaceutical industry
Websitemmpharm.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
49,86 მლრდ.
50,75 მლრდ.
48,00 მლრდ.
51,21 მლრდ.
Cost of goods sold
23,26 მლრდ.
22,49 მლრდ.
21,26 მლრდ.
21,82 მლრდ.
Cost of revenue
23,26 მლრდ.
22,49 მლრდ.
21,26 მლრდ.
21,82 მლრდ.
Research and development expenses
1,20 მლრდ.
1,24 მლრდ.
764,90 მლნ.
904,50 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24,35 მლრდ.
25,30 მლრდ.
25,43 მლრდ.
29,00 მლრდ.
Operating expense
26,15 მლრდ.
26,65 მლრდ.
26,44 მლრდ.
30,23 მლრდ.
Total operating expenses
49,41 მლრდ.
49,14 მლრდ.
47,71 მლრდ.
52,05 მლრდ.
Operating income
453,76 მლნ.
1,61 მლრდ.
293,53 მლნ.
-836,37 მლნ.
Other non operating income
374,15 მლნ.
107,00 მლნ.
1,08 მლნ.
207,74 მლნ.
EBT including unusual items
-377,34 მლნ.
477,71 მლნ.
-931,61 მლნ.
-1,53 მლრდ.
EBT excluding unusual items
-413,37 მლნ.
451,92 მლნ.
-933,44 მლნ.
-1,52 მლრდ.
Income tax expense
290,58 მლნ.
-350,59 მლნ.
104,15 მლნ.
159,64 მლნ.
Effective tax rate
-77,01%
-73,39%
-11,18%
-10,43%
Other operating expenses
513,85 მლნ.
323,27 მლნ.
334,38 მლნ.
459,74 მლნ.
Net income
-548,97 მლნ.
943,18 მლნ.
-801,77 მლნ.
-1,26 მლრდ.
Net profit margin
-1,10%
1,86%
-1,67%
-2,46%
Earnings per share
-
-
-
-
Interest and investment income
12,20 მლნ.
149,26 ათ.
7,57 მლნ.
9,59 მლნ.
Interest expense
-1,27 მლრდ.
-1,28 მლრდ.
-1,25 მლრდ.
-910,05 მლნ.
Net interest expenses
-1,26 მლრდ.
-1,28 მლრდ.
-1,24 მლრდ.
-900,46 მლნ.
Depreciation and amortization charges
175,00 მლნ.
181,03 მლნ.
176,03 მლნ.
178,64 მლნ.
EBITDA
1,47 მლრდ.
2,60 მლრდ.
1,26 მლრდ.
142,52 მლნ.
Gain or loss from assets sale
6,73 მლნ.
-22,85 მლნ.
-3,00 მლნ.
7,00 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები